Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Louise A. Jackett"'
Autor:
Richard A. Scolyer, Victoria Atkinson, David E. Gyorki, Duncan Lambie, Sandra O'Toole, Robyn P.M. Saw, Benhur Amanuel, Christopher M. Angel, Alison E. Button-Sloan, Matteo S. Carlino, Sydney Ch'ng, Andrew J. Colebatch, Dariush Daneshvar, Inês Pires da Silva, Tamara Dawson, Peter M. Ferguson, Erwin Foster-Smith, Stephen B. Fox, Anthony J. Gill, Ruta Gupta, Michael A. Henderson, Angela M. Hong, Julie R. Howle, Louise A. Jackett, Craig James, C. Soon Lee, Alistair Lochhead, Daphne Loh, Grant A. McArthur, Catriona A. McLean, Alexander M. Menzies, Omgo E. Nieweg, Blake H. O'Brien, Thomas E. Pennington, Alison J. Potter, Saurabh Prakash, Robert V. Rawson, Rebecca L. Read, Michael A. Rtshiladze, Kerwin F. Shannon, B. Mark Smithers, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Paul Tucker, Alexander H.R. Varey, Ricardo E. Vilain, Benjamin A. Wood, Georgina V. Long
Publikováno v:
Pathology. 54:6-19
Targeted therapy (BRAF inhibitor plus MEK inhibitor) is now among the possible treatment options for patients with BRAF mutation-positive stage III or stage IV melanoma. This makes prompt BRAF mutation testing an important step in the management of p
Publikováno v:
Pathology.
Autor:
Phoebe Star, Louise A. Jackett, Karen Cheung, James S. Wilmott, Genevieve Ho, Annika Smith, Georgina V. Long, Richard A. Scolyer, Linda K. Martin
Publikováno v:
Dermatologic Therapy. 35
Treatment with anti-PD1 inhibitors may enhance the risk for developing low grade squamoproliferative skin tumors. Immunohistochemical (IHC) analysis of the immune tumor microenvironment (TME) allows exploration of the pathogenesis and relationship wi
Publikováno v:
Transplantation. 106:e348-e349